Eye movement patterns and prescribed mental health medication use
About this title
Read the official source — NCT07389473Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
What will I do during this study?
Adults ages 18–65 who have taken a prescribed psychiatric medicine for more than three months may be eligible for this Philadelphia study. Researchers use an eye-movement device and compare participants taking these medicines with a control group not taking them. The study is evaluating the device; it does not establish that eye movements can identify a medicine or its effects. Other eligibility criteria apply.
- Listed locations
- PhiladelphiaSee all locations and recruitment
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 50
- Sponsor
- Gaize
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT07389473
- Official title
Show the full official title
An Observational Study to Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device
Recruitment & locations
Philadelphia
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Gaize.
Does this study involve medication?
Yes. The study involves medication, including Prescription Psychotropic Medications.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
